Literature DB >> 21723618

Validation of simple visual-analogue thermometer screen for mood complications of cardiovascular disease: the Emotion Thermometers.

Alex J Mitchell1, Joshua P Morgan, Denise Petersen, Sharon Fabbri, Carlos Fayard, Liset Stoletniy, Jun Chiong.   

Abstract

OBJECTIVE: Conventional scales may help with the identification of depression but are generally too lengthy for clinical practice and perform poorly against anxiety and distress. We therefore examined the value of a single item NCCN Distress Thermometer and an enhanced visual-analogue method (Emotion Thermometers, ET) that incorporates four emotion thermometers.
METHODS: We examined 228 patients with mixed cardiovascular conditions of whom 200 completed questionnaires. 64.5% suffered from cardiomyopathy/congestive heart failure, 9.5% had coronary artery disease, 4.5% had multiple cardiac diagnoses, 3% suffered from hypertension, 2% had rhythm problem, 2% had valve problems and 1.5% were diagnosed with atrial fibrillation. We used DSM-IV criteria to define current depression, the GAD7 to define current anxiety and the HADS-T to define distress. 13% had DSM-IV MDD and 19.1% had major or minor depression using DSM-IV (any depression). There were also 59 people (29.6%) with clinically significant distress and 46 with clinically significant anxiety (23.1%).
RESULTS: The optimal accuracy for major depression was either the Depression thermometer (DepT) or the Help thermometer (HelpT), as both performed well. They had a sensitivity and specificity of 73.1%, 89.7% and 84.6%, 85.6%, respectively. The DepT was also best for detecting any DSM-IV depression (sensitivity 68.4% and specificity 93.2%) and HAD-T based distress (sensitivity 79.7% and specificity 82.9%). The Anxiety thermometer (AnxT) performed best against the GAD7 (sensitivity 84.8% and specificity 83.7%).
CONCLUSION: Innovative visual-analogue screening tools for mood appear to perform well in cardiovascular settings.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21723618     DOI: 10.1016/j.jad.2011.06.008

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  SafeFit Trial: virtual clinics to deliver a multimodal intervention to improve psychological and physical well-being in people with cancer. Protocol of a COVID-19 targeted non-randomised phase III trial.

Authors:  Chloe Grimmett; Andrew Bates; Malcolm West; Samantha Leggett; Judit Varkonyi-Sepp; Anna Campbell; June Davis; Stephen Wootton; Clare Shaw; Rachael Barlow; Joanna Ashcroft; Andrew Scott; Helen Moyes; Lesley Hawkins; Denny Z H Levett; Fran Williams; Michael P W Grocott; Sandy Jack
Journal:  BMJ Open       Date:  2021-08-26       Impact factor: 2.692

2.  Effects of Music Therapy in the Reduction of Pre-Meal Anxiety in Patients Suffering from Anorexia Nervosa.

Authors:  Enrico Ceccato; Cristina Roveran
Journal:  Brain Sci       Date:  2022-06-19

3.  Normative values for the distress thermometer (DT) and the emotion thermometers (ET), derived from a German general population sample.

Authors:  Andreas Hinz; Alex J Mitchell; Csaba L Dégi; Anja Mehnert-Theuerkauf
Journal:  Qual Life Res       Date:  2018-10-03       Impact factor: 4.147

4.  Effects of stress, health competence, and social support on depressive symptoms after cardiac hospitalization.

Authors:  Gabriela León-Pérez; Kenneth A Wallston; Kathryn M Goggins; Heidi M Poppendeck; Sunil Kripalani
Journal:  J Behav Med       Date:  2015-12-11

5.  Cell Phone Application to Monitor Pain and Quality of Life in Neurogenic Pain Patients.

Authors:  Rachita Sood; Jenna R Stoehr; Lindsay E Janes; Jason H Ko; Gregory A Dumanian; Sumanas W Jordan
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-29

6.  Protocol for the development and validation of a measure of persistent psychological and emotional distress in cardiac patients: the Cardiac Distress Inventory.

Authors:  Alun Jackson; Michelle Rogerson; Michael Le Grande; David Thompson; Chantal Ski; Marlies Alvarenga; John Amerena; Rosemary Higgins; Michela Raciti; Barbara M Murphy
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.